Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pdb83 - A Systematic Review of Economic Evaluations in Non-Insulin Antidiabetic Treatments for Patients With Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Systematic Review and Network Meta-Analysis of Anti-Diabetes Treatments for Adults With Type 2 Diabetes Mellitus Inadequately Controlled on Insulin and Oral Anti-Diabetes Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

PDB40 Economic Burden of Type 2 Diabetes Mellitus in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Antibody-Mediated Oral Delivery of Therapeutic DNA for Type 2 Diabetes Mellitus

Biomaterials Research
MedicineBiomaterialsCompositesBiomedical EngineeringCeramics
2018English

Review of Utility Values for Economic Modeling in Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Colesevelam for Type 2 Diabetes Mellitus: An Abridged Cochrane Review*

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Pharmacological Treatments for Type 2 Diabetes

2015English

Different Experimental Models Used to Induce Diabetes Mellitus in Rodents: A Review

International Journal of Current Pharmaceutical Research
Pharmaceutical Science
2019English

Role of Conventional Oral Antidiabetic Drugs in Management of Type 2 Diabetes Mellitus

International Journal of Research in Medical Sciences
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy